Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) - Concepedia

Concepedia

Publication | Open Access

Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

DOI Full Paper Access

37

Citations

23

References

2020

Year

Rosa de Miguel Buckley, David Rial‐Crestelo, Lourdes Domínguez, Rocío Montejano, Andrés Esteban-Cantos, Paula Aranguren-Rivas, Natalia Stella-Ascariz, Otilia Bisbal, Laura Bermejo-Plaza, Mónica García–Álvarez,

References

	Year	Citations

Page 1